Arkolith/Insider Trading/ETTX/Form 4

Mueller John Patrick

Chief Development OfficerEntasis Therapeutics Holdings Inc. (ETTX) · full profile →Form 4 · filed Oct 20, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 19, 2021Sell(S)4K$3.19$13K46K
Oct 19, 2021Grant(A)25K—$050K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-128062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML